Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-05

Clinical Trial Update: Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dutogliptin in combination with filgrastim for early recovery after ST-elevation myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dutogliptin (dutogliptin)
  • Filgrastim (filgrastim)

Snippet

Sponsor: Recardio, Inc. | Conditions: ST Elevation Myocardial Infarction | Phase 3 | Status: UNKNOWN